NBF006 is a novel lyophilized lipid NP formulation, which delivers a siRNA inhibiting the expression of glutathione-S-transferase P that is strongly up-regulated in many cancer types, especially in KRAS-driven tumors [98]. This evidence concerns the gene KRAS and cancer.